Pulsatilla saponin E suppresses viability, migration, invasion and promotes apoptosis of NSCLC cells through negatively regulating Akt/FASN pathway via inhibition of flotillin-2 in lipid raft

References

• Nasim F, Sabath BF, Eapen GA. Lung cancer. Med Clin North Am. 2019;103(3):463–473.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Luo J, Zhu H, Jiang H, et al. The effects of aberrant expression of LncRNA DGCR5/miR-873-5p/TUSC3 in lung cancer cell progression. Cancer Med. 2018;7(7):3331–3341.
   PubMed Web of Science ®Google Scholar
• Liang H, Yan X, Pan Y, et al. MicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3. Mol Cancer. 2015;14(1):58–71.
   PubMed Web of Science ®Google Scholar
• Peng F, Li Q, Niu SQ, et al. ZWINT is the next potential target for lung cancer therapy. J Cancer Res Clin Oncol. 2019;145(3):661–673.
   PubMed Web of Science ®Google Scholar
• Y-Hh E. General survey of traditional Chinese medicine and western medicine researches on tumor metastasis. Chin J Integr Med. 2006;12(1):75–80.
   PubMedGoogle Scholar
• Layne K, Ferro A. Traditional Chinese medicines in the management of cardiovascular diseases: a comprehensive systematic review. Br J Clin Pharmacol. 2017;83(1):20–32.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zhou F, Wu X, et al. 23-Hydroxybetulinic acid from Pulsatilla chinensis (Bunge) regel synergizes the antitumor activities of doxorubicin in vitro and in vivo. J Ethnopharmacol. 2010;128(3):615–622.
   PubMed Web of Science ®Google Scholar
• Chang-Ling L, Jiao L, Yuan-Yuan L, et al. Research progress of pharmacological effects of Pulsatilla chinensis. Anim Husbandry Feed Sci. 2019;40(3):94–97.
   Google Scholar
• Liu Q, Chen W, Jiao Y, et al. Pulsatilla saponin A, an active molecule from Pulsatilla chinensis, induces cancer cell death and inhibits tumor growth in mouse xenograft models. J Surg Res. 2014;188(2):387–395.
   PubMed Web of Science ®Google Scholar
• Xu L, Cheng G, Lu Y, et al. An active molecule from Pulsatilla chinensis, Pulsatilla saponin A, induces apoptosis and inhibits tumor growth of human colon cancer cells without or with 5-FU. Oncol Lett. 2017;13(5):3799–3802.
   PubMed Web of Science ®Google Scholar
• Son MK, Jung KH, Hong SW, et al. SB365, Pulsatilla saponin D suppresses the proliferation of human colon cancer cells and induces apoptosis by modulating the AKT/mTOR signalling pathway. Food Chem. 2013;136(1):26–33.
   PubMed Web of Science ®Google Scholar
• Son MK, Jung KH, Lee HS, et al. SB365, Pulsatilla saponin D suppresses proliferation and induces apoptosis of pancreatic cancer cells. Oncol Rep. 2013;30(2):801–808.
   PubMed Web of Science ®Google Scholar
• Sezgin E, Levental I, Mayor S, et al. The mystery of membrane organization: composition, regulation and roles of lipid rafts. Nat Rev Mol Cell Biol. 2017;18(6):361–374.
   PubMed Web of Science ®Google Scholar
• Mollinedo F, Gajate C. Lipid rafts as major platforms for signaling regulation in cancer. Adv Biol Regul. 2015;57:130–146.
   PubMedGoogle Scholar
• Liu J, Huang W, Ren C, et al. Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathways. Sci Rep. 2015;5:11614.
   PubMed Web of Science ®Google Scholar
• Xie G, Li J, Chen J, et al. Knockdown of flotillin-2 impairs the proliferation of breast cancer cells through modulation of Akt/FOXO signaling. Oncol Rep. 2015;33(5):2285–2290.
   PubMed Web of Science ®Google Scholar
• Rakheja D, Kapur P, Hoang MP, et al. Increased ratio of saturated to unsaturated C18 fatty acids in colonic adenocarcinoma: implications for cryotherapy and lipid raft function. Med Hypotheses. 2005;65(6):1120–1123.
   PubMed Web of Science ®Google Scholar
• Hung CM, Kuo DH, Chou CH, et al. Osthole suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition via repression of the c-Met/Akt/mTOR pathway in human breast cancer cells. J Agric Food Chem. 2011;59(17):9683–9690.
   PubMed Web of Science ®Google Scholar
• Hu J, Che L, Li L, et al. Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice. Sci Rep. 2016;6:20484.
   PubMed Web of Science ®Google Scholar
• Wen S, Niu Y, Lee SO, et al. Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells. Mol Carcinog. 2016;55(12):2278–2290.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Gardiner RE, Jahangeer S, Forde P, et al. Low immunogenicity in non-small cell lung cancer; do new developments and novel treatments have a role? Cancer Metastasis Rev. 2015;34(1):129–144.
   PubMed Web of Science ®Google Scholar
• Kramer N, Walzl A, Unger C, et al. In vitro cell migration and invasion assays. Mutat Res. 2013;752(1):10–24.
   PubMed Web of Science ®Google Scholar
• Duff D, Long A. Roles for RACK1 in cancer cell migration and invasion. Cell Signal. 2017;35:250–255.
   PubMed Web of Science ®Google Scholar
• Diederichs S, Bulk E, Steffen B, et al. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res. 2004;64(16):5564–5569.
   PubMed Web of Science ®Google Scholar
• Kabouridis PS, Janzen J, Magee AL, et al. Cholesterol depletion disrupts lipid rafts and modulates the activity of multiple signaling pathways in T lymphocytes. Eur J Immunol. 2000;30(3):954–963.
   PubMed Web of Science ®Google Scholar
• Ge L, Qi W, Wang LJ, et al. Flotillins play an essential role in Niemann-Pick C1-like 1-mediated cholesterol uptake. Proc Natl Acad Sci USA. 2011;108(2):551–556.
   PubMed Web of Science ®Google Scholar
• Slaughter N, Laux I, Tu X, et al. The flotillins are integral membrane proteins in lipid rafts that contain TCR-associated signaling components: implications for T-cell activation. Clin Immunol. 2003;108(2):138–151.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhu LB, Peng AF, et al. LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3 kinase/Akt/fatty acid synthase signaling pathway in vitro. Mol Med Rep. 2015;11(2):1352–1357.
   PubMed Web of Science ®Google Scholar
• Yang WB, Zhang WP, Shi JL, et al. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway. Eur Rev Med Pharmacol Sci. 2018;22(11):3408–3414.
   PubMed Web of Science ®Google Scholar
• Hu J, Zhang L, Chen Q, et al. Knockdown of CPEB4 expression suppresses cell migration and invasion via Akt pathway in non-small cell lung cancer. Cell Biol Int. 2018;42(11):1484–1491.
   PubMed Web of Science ®Google Scholar
• Lee YC, Lin HH, Hsu CH, et al. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway. Eur J Pharmacol. 2010;632(1–3):23–32.
   PubMed Web of Science ®Google Scholar
• Sankaranarayanapillai M, Zhang N, Baggerly KA, et al. Metabolic shifts induced by fatty acid synthase inhibitor orlistat in non-small cell lung carcinoma cells provide novel pharmacodynamic biomarkers for positron emission tomography and magnetic resonance spectroscopy. Mol Imaging Biol. 2013;15(2):136–147.
   PubMed Web of Science ®Google Scholar
• Chang L, Fang S, Chen Y, et al. Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway. Lipids Health Dis. 2019;18(1):118.
   PubMedGoogle Scholar
• Arkhipova KA, Sheyderman AN, Laktionov KK, et al. Simultaneous expression of flotillin-1, flotillin-2, stomatin and caveolin-1 in non-small cell lung cancer and soft tissue sarcomas. BMC Cancer. 2014;14:100.
   PubMed Web of Science ®Google Scholar
• Gao F, Wu H, Wang R, et al. MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2. Bioengineered. 2019;10(1):1–12.
   PubMed Web of Science ®Google Scholar
• Wei G, Xu Y, Peng T, et al. miR-133 involves in lung adenocarcinoma cell metastasis by targeting FLOT2. Artif Cells Nanomed Biotechnol. 2018;46(2):224–230.
   PubMed Web of Science ®Google Scholar
• Cao K, Xie D, Cao P, et al. SiRNA-mediated flotillin-2 (Flot2) downregulation inhibits cell proliferation, migration, and invasion in gastric carcinoma cells. Oncol Res. 2014;21(5):271–279.
   PubMed Web of Science ®Google Scholar
• Yan Y, Yang FQ, Zhang HM, et al. Up-regulation of flotillin-2 is associated with renal cell carcinoma progression. Tumour Biol. 2014;35(10):10479–10486.
   PubMedGoogle Scholar